Status:
UNKNOWN
Usefulness of Markers to Predict Recurrence of Atrial Fibrillation After Radiofrequency Catheter Ablation
Lead Sponsor:
University Hospital, Geneva
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18-80 years
Brief Summary
Catheter ablation using radiofrequency is a new therapeutic tool to treat atrial fibrillation with a higher success rate than medical therapy (80% versus less than 50% respectively). Because of the le...
Detailed Description
Catheter ablation of atrial fibrillation is a recent therapeutic tool to treat atrial fibrillation. The success rate of eliminating atrial fibrillation by radiofrequency catheter ablation is 80 %, aft...
Eligibility Criteria
Inclusion
- atrial fibrillation
- indication for catheter ablation of atrial fibrillation
Exclusion
- significant valvulopathy
- previous catheter ablation for atrial fibrillation or atrial flutter
- left ventricular ejection fraction \< 30%
- Severe heart failure (NYHA IV)
- Severe enlargement of left atrium (\> 55mm)
Key Trial Info
Start Date :
April 1 2004
Trial Type :
OBSERVATIONAL
End Date :
August 1 2007
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT00315068
Start Date
April 1 2004
End Date
August 1 2007
Last Update
April 20 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiology Division University Hospital
Geneva, Canton of Geneva, Switzerland, 1211